Turnstone Biologics Competitors and Similar CompaniesClear all
Turnstone Biologics's competitors and similar companies include Vyripharm Biopharmaceuticals, Innate Pharma, Scimega and Peptomyc.
 Vyripharm Biopharmaceuticals Vyripharm Biopharmaceuticals is a company focused on developing treatments for neurological disorders and infectious diseases. |  Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. |  Peptomyc Peptomyc is a company focused on the development of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. | |||
Founding Date | Founding Date 2015 | Founding Date 2019 | Founding Date 1999 | Founding Date 1997 | Founding Date 2014 |
Type | Type Public | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ Ottawa, CA | Locations Dallas, US HQ | Locations Marseille, FR HQ Rockville, US | Locations Laval, CA HQ | Locations Barcelona, ES HQ |
Employees | Employees 112 | Employees 5 | Employees 181 | Employees 20 | Employees 20 |
Valuation ($) | Valuation ($) 11.6 m | Valuation ($) N/A | Valuation ($) 148.6 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($70.8m) (FY, 2024) | Net income N/A | Net income (€49.2m) (FY, 2025) | Net income N/A | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Vyripharm Biopharmaceuticals
HQ
Dallas, US
Vyripharm Biopharmaceuticals is a company focused on developing treatments for neurological disorders and infectious diseases.
View companyInnate Pharma
HQ
Marseille, FR
Employees
181
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View companyPeptomyc
HQ
Barcelona, ES
Employees
20
Peptomyc is a company focused on the development of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment.
View company